Back to top
more

Stevanato Group (STVN)

(Real Time Quote from BATS)

$27.48 USD

27.48
77,740

-0.04 (-0.15%)

Updated Apr 26, 2024 11:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for STVN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Stevanato Group SpA falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 80 276 519 180 -99,999
Receivables 390 281 256 179 NA
Notes Receivable 0 0 0 0 NA
Inventories 276 225 176 159 NA
Other Current Assets 187 109 74 45 NA
Total Current Assets 933 891 1,025 563 NA
Net Property & Equipment 1,113 676 465 358 NA
Investments & Advances 1 1 1 3 NA
Other Non-Current Assets 0 0 0 0 NA
Deferred Charges 83 73 66 52 NA
Intangibles 88 84 94 93 NA
Deposits & Other Assets 5 4 2 8 NA
Total Assets 2,242 1,749 1,679 1,106 NA
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 NA
Accounts Payable 301 252 195 136 NA
Current Portion Long-Term Debt 155 75 55 93 NA
Current Portion Capital Leases 0 0 0 0 NA
Accrued Expenses 0 0 0 0 NA
Income Taxes Payable 33 44 23 22 NA
Other Current Liabilities 133 117 128 111 NA
Total Current Liabilities 622 487 401 361 NA
Mortgages 0 0 0 0 NA
Deferred Taxes/Income 10 22 23 13 NA
Convertible Debt 0 0 0 0 NA
Long-Term Debt 277 156 239 336 NA
Non-Current Capital Leases 0 0 0 0 NA
Other Non-Current Liabilities 107 34 20 41 NA
Minority Interest (Liabilities) 0 0 0 0 NA
Total Liabilities 1,016 699 683 751 NA
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 NA
Common Stock (Par) 23 23 26 23 NA
Capital Surplus 0 0 0 0 NA
Retained Earnings 1,202 1,027 971 332 NA
Other Equity 0 0 0 0 NA
Treasury Stock 0 0 0 0 NA
Total Shareholder's Equity 1,226 1,049 996 354 NA
Total Liabilities & Shareholder's Equity 2,242 1,749 1,679 1,106 NA
Total Common Equity 1,226 1,049 996 354 0
Shares Outstanding 295.50 295.50 295.50 NA NA
Book Value Per Share 4.15 3.55 3.37 0.00 0.00

Fiscal Year End for Stevanato Group SpA falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 80 73 72 192
Receivables NA 390 311 327 318
Notes Receivable NA 0 0 0 0
Inventories NA 276 302 294 263
Other Current Assets NA 187 173 146 119
Total Current Assets NA 933 858 839 892
Net Property & Equipment NA 1,113 1,054 940 793
Investments & Advances NA 1 1 1 1
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 83 78 84 78
Intangibles NA 88 83 84 84
Deposits & Other Assets NA 5 6 6 4
Total Assets NA 2,242 2,097 1,972 1,871
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 301 262 291 253
Current Portion Long-Term Debt NA 155 110 74 91
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 33 66 75 57
Other Current Liabilities NA 133 171 176 153
Total Current Liabilities NA 622 609 617 554
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 10 10 23 22
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 277 214 132 154
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 70 51 36
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,016 904 823 765
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 23 24 24 23
Capital Surplus NA 0 0 0 0
Retained Earnings NA 1,202 1,170 1,126 1,083
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 1,226 1,194 1,149 1,106
Total Liabilities & Shareholder's Equity NA 2,242 2,097 1,972 1,871
Total Common Equity 0 1,226 1,194 1,149 1,106
Shares Outstanding NA 295.50 295.50 295.50 295.50
Book Value Per Share 0.00 4.15 4.04 3.89 3.74